BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 2758224)

  • 1. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive inotropy contributes to the hemodynamic mechanism of action of flosequinan (BTS 49465) in the intact dog.
    Greenberg S; Touhey B
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):900-10. PubMed ID: 1694912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
    Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action.
    Gristwood RW; Comer MB; Eden RJ; Taylor EM; Turner JA; Wallduck M; Owen DA
    Br J Pharmacol; 1988 Apr; 93(4):893-901. PubMed ID: 3390657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic selectivity of salbutamol and terbutaline in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1985 Oct; 116(1-2):97-104. PubMed ID: 4054218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular pharmacology of the vasodilator-cardiotonic agent, 349U85.
    Steffen RP; Wastila WB
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):579-89. PubMed ID: 1280714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Jun; 51(2):169-77. PubMed ID: 4155970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption.
    Greenberg S; Touhey B; Paul J
    Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivo.
    Law WR; Carney PJ; McLane MP
    Cardiovasc Res; 1991 Feb; 25(2):151-7. PubMed ID: 1742765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog.
    Endoh M; Shimizu T; Yanagisawa T
    Br J Pharmacol; 1978 Sep; 64(1):53-61. PubMed ID: 29684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):425-34. PubMed ID: 2438505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive inotropic effects of histamine in anaesthetized dogs.
    Einstein R; Mihailidou AS; Richardson DP
    Br J Pharmacol; 1987 Oct; 92(2):445-50. PubMed ID: 2890394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic mechanisms of dopexamine hydrochloride in horses.
    Muir WW
    Am J Vet Res; 1992 Aug; 53(8):1343-6. PubMed ID: 1354950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiac pharmacology of tolbutamide.
    Curtis GP; Setchfield J; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jul; 194(1):264-73. PubMed ID: 1151754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.